(HealthDay News) — A wearable device may improve physical activity, physical function, dyspnea, and pain after lung cancer surgery, according to a study published in JAMA Network Open.
NextRNA Therapeutics, a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases, today announced the appointment of Jesse Smith, Ph ...
Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug ...